Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Fish and Richardson
Citi
Medtronic
Johnson and Johnson
Fuji
Mallinckrodt
Julphar
Chubb

Generated: January 18, 2018

DrugPatentWatch Database Preview

CHOLOXIN Drug Profile

« Back to Dashboard

When do Choloxin patents expire, and what generic alternatives are available?

Choloxin is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in CHOLOXIN is dextrothyroxine sodium. Additional details are available on the dextrothyroxine sodium profile page.

US Patents and Regulatory Information for CHOLOXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie CHOLOXIN dextrothyroxine sodium TABLET;ORAL 012302-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie CHOLOXIN dextrothyroxine sodium TABLET;ORAL 012302-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie CHOLOXIN dextrothyroxine sodium TABLET;ORAL 012302-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie CHOLOXIN dextrothyroxine sodium TABLET;ORAL 012302-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
Cerilliant
AstraZeneca
Baxter
Express Scripts
Fish and Richardson
Boehringer Ingelheim
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot